Company / Revenue per Share
Cocrystal Pharma, Inc. Revenue per Share History
FY2019-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$0.19
FY2020
5-year range
$0.19 / $0.22
FY2019-FY2020
Trend
-14.8%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
0.19 in FY2020.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2020, revenue per share decreased 14.8% year-over-year.
Company context
Key Data Points
- Altman Z-Score 14.87 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2021 | - | - |
| FY2020 | $0.19 | -14.8% |
| FY2019 | $0.22 | - |
| FY2012 | - | - |
As of FY2020 · SEC 10-K · Updated Jun 24, 2026